Journal of Multiple Sclerosis

New Discernment of Pathophysiological Aspects of Multiple Sclerosis Based On Mono Amino Oxidase (MAO) and Ion Channel Receptor 5HT3RA as Activator of T-Cells

Toktam Deylami, Mohammad Hossein Sanati and Ghasem Ahangari

Background: Multiple sclerosis (MS) is a chronic, inflammatory and autoimmune disease of central nervous system. MS affects nearly 2.5 million people in the world and is twice more common in women than men. Autoimmune T-cells target the myelin sheath in central nervous system, causing inflammation, demyelination and eventual destruction of neurons. We examined changing expression of serotonin receptor (5-HT₃R_A) as well as monoamine oxidase (MAO-A) genes in peripheral blood mononuclear cells in MS patients.

Materials and methods: In this study, peripheral blood mononuclear cells (PBMC) were first isolated from 30 healthy controls and 30 volunteers with MS using Ficoll-hypaque. Total RNA was extracted and cDNA was synthesized. In this process, mRNA concentration of 5-HT₃R_A and MAO-A as target genes as well as β-actin as reference gene was compared in PBMC of healthy subjects and patients using Real-time PCR.

Results: After statistical analysis of resulting data, a significant increase was observed in the expression of 5-HT₃R_A receptor gene as well as MAO-A gene in PBMC of patients with multiple sclerosis (P=0.001).

Conclusion: According to previous studies on the association between serotonin level with MS importance of 5-HT₃R_A serotonin receptor in the function of this neurotransmitter as well as T-cell activation along with significant increase in the expression of 5-HT₃R_A receptor in MS patients, it can be concluded that overexpression of this receptor has a significant correlation with MS progress. On the other hand, considering the fact that monoamine oxidase is a key enzyme responsible for oxidation of serotonin in the nervous system, perhaps the body is not capable of maintaining normal level of this enzyme in MS patients. Therefore, considerable increase in MAO level may be responsible for reduced level of serotonin in MS patients, which is a likely reason for depression in these patients.